Gwee A, Cranswick N, McMullan B, Bolisetty S, Hunt RW, Curtis N, et al. Defining Target Vancomycin Trough Concentrations for Treating Staphylococcus aureus Infection in Infants Aged 0 to 90 Days. JAMA Pediatr 2019;173(8):791-3. https://www.ncbi.nlm.nih.gov/pubmed/31180478
Gwee A, Duffull SB, Daley AJ, Lim M, Germano S, Bilal H, et al. Identifying a therapeutic target for vancomycin against staphylococci in young infants. J Antimicrob Chemother 2022;77(3):704-10. https://www.ncbi.nlm.nih.gov/pubmed/35037934
Le J, Bradley JS, Murray W, Romanowski GL, Tran TT, Nguyen N, et al. Improved vancomycin dosing in children using area under the curve exposure. Pediatr Infect Dis J 2013;32(4):e155-63. https://www.ncbi.nlm.nih.gov/pubmed/23340565
Ricard JD, Wolff M, Lacherade JC, Mourvillier B, Hidri N, Barnaud G, et al. Levels of vancomycin in cerebrospinal fluid of adult patients receiving adjunctive corticosteroids to treat pneumococcal meningitis: a prospective multicenter observational study. Clin Infect Dis 2007;44(2):250-5. https://www.ncbi.nlm.nih.gov/pubmed/17173226
Rybak M, Lomaestro B, Rotschafer JC, Moellering R, Jr., Craig W, Billeter M, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm 2009;66(1):82-98. https://www.ncbi.nlm.nih.gov/pubmed/19106348
Shokouhi S, Alavi Darazam I. Determination of vancomycin trough level in serum and cerebrospinal fluid of patients with acute community-acquired meningitis: a prospective study. J Infect 2014;69(5):424-9. https://www.ncbi.nlm.nih.gov/pubmed/24973553
